Very early onset inflammatory bowel disease

Semin Pediatr Surg. 2017 Dec;26(6):356-359. doi: 10.1053/j.sempedsurg.2017.10.004. Epub 2017 Oct 10.

Abstract

Very early onset inflammatory bowel disease (VEO-IBD) represents a unique and growing subset of patients with inflammatory bowel disease (IBD). Some VEO-IBD patients present with immunodeficiency and possess loss of function genetic mutations involving immune pathways that cause their IBD. A search for Mendelian causes of IBD is likely most beneficial when the presentation involves extra-intestinal autoimmunity or involves intestinal histopathology that is atypical for IBD. While a subset of these young patients will have highly aggressive courses (and likely present with immunodeficiency), the majority of patients with VEO-IBD appear to have disease courses similar to that of their older counterparts. Most notably, many of these young children will require long courses of immunosuppression simply as a result of the profoundly early presentation-thus increasing their long-term risks of cancer and opportunistic infections.

Keywords: Immunodeficiency; Very early onset IBD.

Publication types

  • Review

MeSH terms

  • Age of Onset
  • Child
  • Child, Preschool
  • Europe / epidemiology
  • Genetic Predisposition to Disease
  • Genetic Testing
  • Humans
  • Immunologic Deficiency Syndromes / complications
  • Immunologic Deficiency Syndromes / diagnosis
  • Immunologic Deficiency Syndromes / genetics
  • Infant
  • Inflammatory Bowel Diseases* / diagnosis
  • Inflammatory Bowel Diseases* / epidemiology
  • Inflammatory Bowel Diseases* / etiology
  • Inflammatory Bowel Diseases* / therapy
  • North America / epidemiology
  • Risk Factors